Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Esophageal Neoplasms | 10 | 2024 | 1676 | 1.820 |
Why?
|
Contractile Proteins | 2 | 2020 | 240 | 1.270 |
Why?
|
Hypertension, Portal | 2 | 2023 | 229 | 0.910 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2020 | 1660 | 0.820 |
Why?
|
Gastritis, Atrophic | 1 | 2022 | 32 | 0.810 |
Why?
|
Papillomavirus Infections | 3 | 2024 | 1637 | 0.750 |
Why?
|
Carcinoma, Verrucous | 1 | 2021 | 27 | 0.750 |
Why?
|
Adenocarcinoma | 8 | 2023 | 6400 | 0.740 |
Why?
|
Immunohistochemistry | 10 | 2024 | 11139 | 0.720 |
Why?
|
Stomach Neoplasms | 5 | 2023 | 1484 | 0.700 |
Why?
|
Gastritis | 1 | 2022 | 200 | 0.690 |
Why?
|
Deoxyribonuclease I | 2 | 2014 | 225 | 0.690 |
Why?
|
Stromal Cells | 3 | 2022 | 1335 | 0.640 |
Why?
|
Gallbladder Neoplasms | 1 | 2020 | 191 | 0.630 |
Why?
|
Helicobacter pylori | 1 | 2022 | 382 | 0.620 |
Why?
|
Helicobacter Infections | 1 | 2022 | 392 | 0.620 |
Why?
|
Hepatic Duct, Common | 1 | 2017 | 48 | 0.590 |
Why?
|
Telomerase | 1 | 2021 | 749 | 0.520 |
Why?
|
beta Catenin | 1 | 2021 | 1048 | 0.520 |
Why?
|
Duodenal Diseases | 1 | 2015 | 101 | 0.490 |
Why?
|
Precancerous Conditions | 1 | 2022 | 988 | 0.490 |
Why?
|
Bile Duct Diseases | 1 | 2014 | 98 | 0.460 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2020 | 617 | 0.460 |
Why?
|
Esophagectomy | 3 | 2023 | 482 | 0.450 |
Why?
|
Cholangiocarcinoma | 2 | 2021 | 563 | 0.450 |
Why?
|
DNA Cleavage | 1 | 2014 | 56 | 0.440 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2024 | 2964 | 0.440 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2014 | 304 | 0.430 |
Why?
|
Liver Cirrhosis | 4 | 2023 | 1950 | 0.430 |
Why?
|
GATA3 Transcription Factor | 1 | 2013 | 164 | 0.420 |
Why?
|
Cholangitis, Sclerosing | 1 | 2014 | 179 | 0.410 |
Why?
|
Glomerulonephritis | 1 | 2014 | 333 | 0.410 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2014 | 289 | 0.410 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 569 | 0.400 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4362 | 0.380 |
Why?
|
Chemotaxis | 1 | 2014 | 601 | 0.380 |
Why?
|
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2014 | 229 | 0.370 |
Why?
|
Inflammatory Bowel Diseases | 4 | 2023 | 2444 | 0.370 |
Why?
|
Adenomatous Polyps | 2 | 2024 | 109 | 0.370 |
Why?
|
Diarrhea | 1 | 2015 | 1320 | 0.310 |
Why?
|
DNA Restriction Enzymes | 1 | 2008 | 548 | 0.310 |
Why?
|
Models, Molecular | 4 | 2009 | 5441 | 0.310 |
Why?
|
Neoadjuvant Therapy | 4 | 2024 | 2896 | 0.310 |
Why?
|
Colitis | 2 | 2014 | 1244 | 0.310 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.300 |
Why?
|
Amyloidosis | 1 | 2015 | 879 | 0.300 |
Why?
|
Liver Failure, Acute | 2 | 2021 | 182 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2544 | 0.290 |
Why?
|
Binding Sites | 2 | 2014 | 6029 | 0.280 |
Why?
|
Weight Loss | 2 | 2015 | 2710 | 0.280 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2013 | 798 | 0.270 |
Why?
|
Protein Folding | 2 | 2008 | 875 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2014 | 1755 | 0.270 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2022 | 4083 | 0.260 |
Why?
|
Intestine, Small | 2 | 2024 | 1218 | 0.260 |
Why?
|
Fatty Liver | 2 | 2022 | 807 | 0.240 |
Why?
|
Hyperplasia | 3 | 2023 | 1154 | 0.240 |
Why?
|
Bacterial Proteins | 2 | 2008 | 3861 | 0.230 |
Why?
|
Observer Variation | 2 | 2021 | 2622 | 0.230 |
Why?
|
Pancreatic Neoplasms | 3 | 2020 | 5443 | 0.220 |
Why?
|
Esophagogastric Junction | 3 | 2023 | 349 | 0.220 |
Why?
|
Neoplasm Metastasis | 1 | 2013 | 4931 | 0.210 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2024 | 171 | 0.200 |
Why?
|
Aberrant Crypt Foci | 1 | 2022 | 12 | 0.200 |
Why?
|
Human papillomavirus 16 | 1 | 2024 | 269 | 0.200 |
Why?
|
Fatty Liver, Alcoholic | 1 | 2022 | 37 | 0.200 |
Why?
|
Colorectal Neoplasms | 4 | 2024 | 6979 | 0.200 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 398 | 0.200 |
Why?
|
Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
Humans | 49 | 2024 | 768369 | 0.190 |
Why?
|
Hepatitis | 1 | 2023 | 228 | 0.190 |
Why?
|
Metaplasia | 1 | 2022 | 326 | 0.190 |
Why?
|
Macrophages | 2 | 2022 | 5797 | 0.180 |
Why?
|
Doxycycline | 2 | 2013 | 347 | 0.180 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2254 | 0.180 |
Why?
|
Early Growth Response Transcription Factors | 1 | 2020 | 32 | 0.180 |
Why?
|
Aged | 19 | 2024 | 171514 | 0.180 |
Why?
|
North America | 1 | 2024 | 1292 | 0.180 |
Why?
|
Amiodarone | 1 | 2022 | 217 | 0.170 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2023 | 2331 | 0.170 |
Why?
|
Antineoplastic Agents | 1 | 2023 | 13709 | 0.170 |
Why?
|
Alkaline Phosphatase | 1 | 2023 | 865 | 0.170 |
Why?
|
Keratins | 1 | 2021 | 502 | 0.170 |
Why?
|
Peripheral Vascular Diseases | 2 | 2013 | 489 | 0.170 |
Why?
|
Middle Aged | 21 | 2024 | 223406 | 0.170 |
Why?
|
Liver Diseases | 2 | 2022 | 1307 | 0.170 |
Why?
|
Gastric Mucosa | 2 | 2013 | 603 | 0.170 |
Why?
|
Liver | 5 | 2023 | 7575 | 0.170 |
Why?
|
Smooth Muscle Tumor | 1 | 2020 | 65 | 0.160 |
Why?
|
Male | 26 | 2024 | 364761 | 0.160 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2023 | 526 | 0.160 |
Why?
|
Female | 29 | 2024 | 396926 | 0.160 |
Why?
|
Goblet Cells | 1 | 2022 | 300 | 0.160 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2020 | 507 | 0.150 |
Why?
|
Receptor, erbB-2 | 2 | 2020 | 2586 | 0.150 |
Why?
|
DNA, Viral | 1 | 2024 | 2203 | 0.140 |
Why?
|
Protein Structure, Quaternary | 2 | 2008 | 428 | 0.140 |
Why?
|
Gastrectomy | 1 | 2021 | 696 | 0.130 |
Why?
|
Gastrointestinal Diseases | 1 | 2024 | 1207 | 0.130 |
Why?
|
Lithiasis | 1 | 2014 | 19 | 0.120 |
Why?
|
Esophagitis | 2 | 2013 | 165 | 0.120 |
Why?
|
Diagnosis, Differential | 3 | 2023 | 13025 | 0.120 |
Why?
|
Gene Rearrangement | 1 | 2020 | 1139 | 0.120 |
Why?
|
Anemia, Sickle Cell | 1 | 2023 | 1065 | 0.120 |
Why?
|
Biopsy | 3 | 2015 | 6816 | 0.120 |
Why?
|
Cholangiography | 1 | 2014 | 182 | 0.120 |
Why?
|
Adult | 16 | 2024 | 223528 | 0.120 |
Why?
|
Fructose | 1 | 2016 | 285 | 0.120 |
Why?
|
Capillaries | 2 | 2014 | 756 | 0.120 |
Why?
|
Bariatric Surgery | 1 | 2024 | 1007 | 0.110 |
Why?
|
Panax notoginseng | 1 | 2013 | 3 | 0.110 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2015 | 506 | 0.110 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2014 | 283 | 0.110 |
Why?
|
Necrosis | 2 | 2014 | 1622 | 0.110 |
Why?
|
Cholelithiasis | 1 | 2014 | 408 | 0.110 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 528 | 0.110 |
Why?
|
Splenectomy | 1 | 2014 | 392 | 0.110 |
Why?
|
Gene Amplification | 2 | 2015 | 1091 | 0.110 |
Why?
|
Down-Regulation | 1 | 2020 | 2942 | 0.110 |
Why?
|
Stomach Diseases | 1 | 2014 | 134 | 0.110 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 699 | 0.100 |
Why?
|
Aged, 80 and over | 8 | 2021 | 59679 | 0.100 |
Why?
|
Duodenum | 1 | 2015 | 495 | 0.100 |
Why?
|
Calcinosis | 1 | 2021 | 1484 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2020 | 959 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2014 | 396 | 0.100 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 551 | 0.100 |
Why?
|
Macrophage Activation | 1 | 2014 | 556 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2022 | 3234 | 0.100 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3669 | 0.100 |
Why?
|
Spectrometry, Fluorescence | 1 | 2014 | 694 | 0.090 |
Why?
|
Carcinoma | 1 | 2023 | 2341 | 0.090 |
Why?
|
Nausea | 1 | 2014 | 682 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3637 | 0.090 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2020 | 2431 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2014 | 887 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2022 | 3047 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 568 | 0.090 |
Why?
|
Obesity | 2 | 2024 | 13065 | 0.090 |
Why?
|
Transcription, Genetic | 1 | 2024 | 7602 | 0.090 |
Why?
|
RNA, Messenger | 2 | 2022 | 12813 | 0.090 |
Why?
|
Pancreatectomy | 1 | 2014 | 824 | 0.090 |
Why?
|
Specimen Handling | 1 | 2014 | 709 | 0.090 |
Why?
|
Plant Extracts | 1 | 2013 | 499 | 0.080 |
Why?
|
Promoter Regions, Genetic | 1 | 2021 | 5803 | 0.080 |
Why?
|
Substrate Specificity | 1 | 2014 | 1775 | 0.080 |
Why?
|
Flucytosine | 1 | 2009 | 33 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2024 | 65408 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2015 | 2525 | 0.080 |
Why?
|
Cytosine Deaminase | 1 | 2009 | 66 | 0.080 |
Why?
|
Synechocystis | 1 | 2008 | 9 | 0.080 |
Why?
|
Epithelial Cells | 1 | 2021 | 3697 | 0.080 |
Why?
|
Bile Duct Neoplasms | 1 | 2014 | 617 | 0.080 |
Why?
|
Creatinine | 1 | 2014 | 1915 | 0.080 |
Why?
|
Sarcoidosis | 1 | 2014 | 539 | 0.080 |
Why?
|
Causality | 1 | 2014 | 1255 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22365 | 0.080 |
Why?
|
Protein Structure, Secondary | 2 | 2008 | 1223 | 0.080 |
Why?
|
Nucleic Acid Conformation | 2 | 2008 | 899 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2020 | 3076 | 0.070 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 939 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2602 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3105 | 0.070 |
Why?
|
Mass Spectrometry | 1 | 2014 | 2204 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3974 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1087 | 0.070 |
Why?
|
Endodeoxyribonucleases | 1 | 2007 | 166 | 0.070 |
Why?
|
Anticonvulsants | 1 | 2016 | 1923 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9261 | 0.070 |
Why?
|
Amino Acid Sequence | 2 | 2008 | 13447 | 0.070 |
Why?
|
Mutation | 3 | 2024 | 30235 | 0.060 |
Why?
|
Thermodynamics | 1 | 2007 | 594 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2023 | 20232 | 0.060 |
Why?
|
Child | 5 | 2024 | 80856 | 0.060 |
Why?
|
Young Adult | 4 | 2024 | 60038 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 2818 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2008 | 17637 | 0.060 |
Why?
|
Lithocholic Acid | 1 | 2024 | 24 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 8081 | 0.060 |
Why?
|
Amino Acid Motifs | 1 | 2007 | 930 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2013 | 7467 | 0.060 |
Why?
|
Introns | 1 | 2007 | 971 | 0.060 |
Why?
|
Apolipoprotein A-I | 1 | 2005 | 305 | 0.060 |
Why?
|
Antigens, CD | 1 | 2014 | 4022 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14725 | 0.060 |
Why?
|
Adolescent | 4 | 2024 | 89163 | 0.060 |
Why?
|
Disease Progression | 2 | 2020 | 13643 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15459 | 0.060 |
Why?
|
DNA, Bacterial | 1 | 2008 | 1474 | 0.060 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 2023 | 76 | 0.050 |
Why?
|
Sodium Azide | 1 | 2002 | 24 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2020 | 22286 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 9425 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1688 | 0.050 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 1986 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2009 | 1061 | 0.050 |
Why?
|
United States | 3 | 2024 | 73120 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8510 | 0.050 |
Why?
|
Proteomics | 1 | 2015 | 3901 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2260 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14766 | 0.050 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 45 | 0.050 |
Why?
|
Thioredoxins | 1 | 2002 | 202 | 0.040 |
Why?
|
Apoptosis | 2 | 2023 | 9526 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2024 | 12242 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 126 | 0.040 |
Why?
|
Comorbidity | 1 | 2014 | 10601 | 0.040 |
Why?
|
Gadolinium DTPA | 1 | 2023 | 823 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2023 | 679 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2023 | 81835 | 0.040 |
Why?
|
Protein Binding | 2 | 2008 | 9376 | 0.040 |
Why?
|
Colonic Polyps | 1 | 2024 | 557 | 0.040 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 218 | 0.040 |
Why?
|
DNA Helicases | 1 | 2023 | 853 | 0.040 |
Why?
|
Child, Preschool | 2 | 2024 | 42620 | 0.040 |
Why?
|
Phenotype | 1 | 2014 | 16712 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2023 | 36840 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 26348 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2076 | 0.030 |
Why?
|
Base Sequence | 1 | 2007 | 12426 | 0.030 |
Why?
|
Colonoscopy | 1 | 2024 | 1412 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3279 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2021 | 1014 | 0.030 |
Why?
|
Hyperammonemia | 1 | 2016 | 80 | 0.030 |
Why?
|
Mentors | 1 | 2021 | 672 | 0.030 |
Why?
|
Protein Engineering | 2 | 2009 | 549 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2021 | 840 | 0.030 |
Why?
|
Phagocytosis | 1 | 2020 | 1531 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 1104 | 0.030 |
Why?
|
Azoxymethane | 1 | 2013 | 32 | 0.030 |
Why?
|
Saponins | 1 | 2013 | 47 | 0.030 |
Why?
|
DNA | 1 | 2007 | 7213 | 0.030 |
Why?
|
Mice | 6 | 2024 | 82051 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2022 | 11674 | 0.030 |
Why?
|
Computer Simulation | 1 | 2007 | 6278 | 0.030 |
Why?
|
Blood Coagulation Disorders | 1 | 2016 | 350 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2021 | 3550 | 0.030 |
Why?
|
Lymphatic Metastasis | 1 | 2021 | 2930 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2013 | 258 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 193 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1706 | 0.030 |
Why?
|
Glucose | 1 | 2024 | 4355 | 0.030 |
Why?
|
Monocytes | 1 | 2022 | 2589 | 0.030 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2013 | 518 | 0.020 |
Why?
|
RNA | 1 | 2022 | 2728 | 0.020 |
Why?
|
Cerebral Palsy | 1 | 2016 | 478 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2002 | 3734 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2016 | 8559 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2013 | 599 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74915 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2016 | 964 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6537 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2013 | 354 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2007 | 9623 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5337 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1568 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2020 | 3335 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2020 | 19035 | 0.020 |
Why?
|
Withholding Treatment | 1 | 2013 | 621 | 0.020 |
Why?
|
Animals | 6 | 2024 | 169424 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1058 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5808 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2009 | 406 | 0.020 |
Why?
|
Base Pair Mismatch | 1 | 2007 | 93 | 0.020 |
Why?
|
Calorimetry | 1 | 2007 | 132 | 0.020 |
Why?
|
Mitochondria | 1 | 2020 | 3672 | 0.020 |
Why?
|
Mutant Proteins | 1 | 2009 | 489 | 0.020 |
Why?
|
Signal Transduction | 2 | 2020 | 23639 | 0.020 |
Why?
|
Prodrugs | 1 | 2009 | 274 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3939 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2023 | 6657 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2408 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12875 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2013 | 1070 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12561 | 0.020 |
Why?
|
Dimerization | 1 | 2007 | 888 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1766 | 0.020 |
Why?
|
Colon | 1 | 2013 | 1804 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2009 | 647 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14483 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 4120 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2014 | 2170 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10490 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5709 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8636 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2007 | 762 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2020 | 17149 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12176 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 510 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2020 | 11928 | 0.010 |
Why?
|
Mice, Nude | 1 | 2009 | 3635 | 0.010 |
Why?
|
Neurons | 1 | 2002 | 9504 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36496 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4570 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6135 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4534 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10863 | 0.010 |
Why?
|
Epilepsy | 1 | 2016 | 3324 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2009 | 3619 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3790 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6241 | 0.010 |
Why?
|
Neoplasms | 1 | 2009 | 22389 | 0.010 |
Why?
|
Risk Assessment | 1 | 2021 | 24310 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40271 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 30031 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18047 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2021 | 15879 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2005 | 1898 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18390 | 0.010 |
Why?
|
Rats | 1 | 2009 | 23839 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6087 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20763 | 0.010 |
Why?
|